Callos Andrew sold CYTK
March 5, 2026 · Form 4 insider transaction
Callos Andrew sold 15,000 shares of Cytokinetics, Incorporated at $61.87 per share, a transaction worth $928.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,000
Price
$61.87
Total value
$928.0K
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 5, 2026
Filing dateMarch 5, 2026
Shares owned after61,440
OwnershipDirect
10b5-1 planNo
AmendedNo